Access to this resource on the server is denied! Proudly powered by LiteSpeed Web ServerPlease be advised that LiteSpeed Technologies Inc. is not a web hosting company and, as such, has no control over content found on this site. A One-Time Intervention for Type 2 Diabetes Over 200 million people may benefit from our therapy Type 2 diabetes already affects over 400 million people, of which 60% are obese. DIAMOND is an alternative to injectable therapies (insulin, GLP-1 agonists and others) intended to treat obese type 2 diabetes patients who are resistant to oral medication. DIAMOND will improve the lives of millions of people. Patients under insulin, or other injectable medication, face a variety of challenges affecting their day-to-day life. Often two or more daily blood sugar tests are needed and some patients may require four or more injections per day. Common side effects and complications of insulin therapy include weight gain, hypertension and, in severe cases, hypoglycemia shocks requiring hospitalization.

Additionally, many patients cannot tolerate GLP-1 agonist therapy due to nausea, vomiting and other gastrointestinal disturbances. Indoor Greenhouse LightThese challenges ultimately lead to a lower compliance rate, further complications and increased healthcare costs.Kitchen Curtains With Wine Bottles DIAMOND therapy is as effective as insulin, but avoids the associated challenges and side effects. Buy Hdmi Cable To Connect Laptop To TvHow does it work? A small pacemaker-like device is implanted under the abdominal skin and connected by electrodes to the stomach, in a minimally invasive procedure. The device automatically detects when eating begins and sends gentle pulse signals (gastric contractility modulation signals, or GCM) to the stomach muscles.

As a result, the DIAMOND restores the physiological synchronization between food intake and natural hormone secretion, and lowers post meal glucose levels. Additionally, GCM signals cause an earlier satiation effect resulting in sustained weight loss. The DIAMOND therapy is completely reversible and does not affect the physiology of the body. HbA1c reduction of 1% Sustained long term results >300 patients treated in clinical studies,>8 years clinical experience DIAMOND is a one-time intervention Does not cause hypoglycemia No daily needles, no compliance issues Sustained and significant weight lossand blood pressure reduction This small pulse generator is implanted under the abdominal skin and connected with leads to the stomach to deliver the DIAMOND therapy. The device is only 30 cc in volume and allows wireless recharging. It can be used for up to 15 years before a replacement is needed. DIAMOND has received CE mark and is approved for sale in Europe, Australia and other international markets.

DIAMOND is not approved for use in the USA. The tablet is used by certified physicians to set and control the therapy parameters of the implantable device through a wireless interface. Image used for illustrative purposes only, actual tablet model may vary. This external device is used to charge the implanted device wirelessly once a week by the patient at home. Charging time is around 45 minutes. To fight the global diabetes pandemic, we would ideally have an accessible cost-effective easily-compliant intervention… Prof. Harold Lebovitz, New YorkGES [DIAMOND] improves glycemic control and reduces body weight. Hormone & Metabolic Research 20152 For the first time in many years, I have hope. I now believe I can be there for my family and see my children have their own children. I can grow old with my wife. I can live the life that I want to live. Mr. Lo, a type 2 diabetes patient under DIAMOND therapy Randomized trials indicate patients implanted with the DIAMOND experience long term improvement in glycemic control as well as an improvement in other metabolic parameters.

Prof. Bai Rixing, Beijing We listened to physicians and diabetic patients and developed a new solution to make patients lives better. Dr. Mateusz Zelewski, CEO Over 300 patients treated in clinical trials improved their glycemic control observation period in our long-term study Significant and sustained results over several years Sustained weight loss of 5 – 10Kg and significant reduction of blood pressure by 10 mmHg [1] Lebovitz H.E., Zalewski M., Gastric Electrical Stimulation (GES) in T2DM Improves Long-term Glycemic Control Through a Triglyceride-dependent Mechanism; Presented at the IDF World Diabetes Congress Melbourne 2013, December 3, 2013, Melbourne. [2] Lebovitz HE, Ludvik B, Yaniv I, et al. Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years. Horm Metab Res. 2015;47(6):456-62. [3] Wong SK, Kong AP, Luk AO, et al.

A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes. [4] Lebovitz HE, Ludvik B, Kozakowski J, et al. Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial. [5] Lebovitz HE, Ludvik B, Yaniv I, et al. Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm. [6] Bohdjalian A, Prager G, Rosak C, et al. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. [7] Sanmiguel CP, Conklin JL, Cunneen SA, et al. Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol. 2009;3(4):964-70. [8] Bohdjalian A, Prager G, Aviv R, et al. One-year experience with Tantalus: a new surgical approach to treat morbid obesity.